Yesterday's 貿易（する）ing: AZ 株 決起大会／結集させる

By GEOFF FOSTER FOR MAILONLINE
Updated: 08:24 BST, 6 December 2007

?

株 of AstraZeneca have been in need of some tender loving care since the UK's second biggest 製薬のs group forked out a stonking £7.8bn on MedImmune in June, after winning a hotly contested auction two months earlier.

Many City 分析家s are of the opinion that 長，指導者 (n)役員／(a)執行力のある David Brennan had overpaid, even some knew very little about the Marylandbased com pany. 投資家s have since 砂漠d in their droves and the 株 have fallen はっきりと from a pre-取引，協定 level of 2950p.

They 決起大会／結集させるd 39p to 2301p yesterday on hopes that tomorrow's 'Biologics Day' 贈呈 at MedImmune's （警察，軍隊などの）本部 in Gaithersburg will see Brennan bang the 派手に宣伝する and 納得させる the multitude of number crunchers that it definitely is 価値（がある） every penny.

During a five hour 贈呈, he will probably repeat that he 計画（する）s to build it into a standalone 子会社 焦点（を合わせる）d 完全に on developing 'biologic' 麻薬s - those produced from living 構成要素s rather than 従来の 製薬のs.

The 取得／買収 at a 一打／打撃 gave AZ 接近 to flu ワクチンs, an antiviral 治療 for babies and about 45 実験の 麻薬s. Brennan 取って代わるd Sir Tom McKillop as 長，指導者 (n)役員／(a)執行力のある two years ago and has had a rollercoaster ride.

Eyebrows were raised when he bought biotech 巨大（な） Cambridge Antibody 科学（工学）技術 for £702m last year. He then 扇動するd a major cost 削減 programme with the loss of 7,800 職業s 世界的な after a number of 重要な 麻薬s failed during 臨床の 裁判，公判s.

He also lost his 井戸／弁護士席 尊敬（する）・点d 財政／金融 director, Jon Symonds, to Goldman Sachs, 取って代わるing him since with Simon Lowth, who arrived in November from Scottish 力／強力にする.

競争相手 麻薬s 巨大（な） GlaxoSmithKline 伸び（る）d 16p to 1304p, up from a 最近の year's low of 1160p. 投資家s are 希望に満ちた that Andrew Witty, who 後継するs ジーンズ-Pierre Garnier as 長，指導者 (n)役員／(a)執行力のある in May, has some exciting 計画（する）s up his sleeve.

Word is he is a dealmaker. 仲買人 Panmure Gordon recently said that GSK's oncology pipeline is transformational and could 追加する a その上の 193p per 株 to 逮捕する 現在の value.

What a difference a day makes. Twenty four little hours after 株 had moved はっきりと south on 期待s UK 利益／興味 率s would be left on 持つ／拘留する today, the Footsie 急に上がるd 178.6 points to 6,493.8 on 超高層ビル high hopes that Mervyn King and his merry men at the Bank of England will 削減（する） 率s by ?%, or even ?%, at no on today.

出版（物） of weak 住宅 and services 部門 data, which （機の）カム hard on the heels of the FSA's 警告 about the 悲惨な consequences of the credit crunch, 納得させるd bulls that King & Co will surely have to relieve the 圧力 on a demoralised UK 住宅 market and shellshocked mortgage owners.

塀で囲む Street 殺到するd 179 points in 早期に 貿易（する）ing on news that US 労働者 生産性 殺到するd the most since 2003 in the third-４半期/4分の1 and 労働 costs 地位，任命するd the biggest 拒絶する／低下する in four years. A その上の ?% 削減 in US 利益／興味 率s next week now looks rubberstamped.

A combination of 勇敢に立ち向かう buying and 耐える の近くにing ahead of today's 貿易（する）ing 声明 helped 王室の Bank of Scotland 決起大会／結集させる 26?p to 465?p. 売買業者s 推定する／予想する 令状-offs up to £2bn 予定 to the credit crunch.

Xstrata's (138p up at 3458p) £408m cash 企て，努力，提案 for coal 鉱夫 資源 太平洋の 増加するd 期待s that there are plenty more 取引，協定s to come in the 採掘 部門. Still hoping that Baosteel, 中国's 最高の，を越す 鉄鋼業, will soon 最高の，を越す BHP's £67bn 申し込む／申し出, Rio Tinto 殺到するd 205p to 5720p. Vedanta 資源s 追加するd 120p at 2344p and Anglo American 155p to 3273p.

生き返らせるd 思索的な buying on 企て，努力，提案 talk helped Colt Telecom buzz 21p higher to 206p.

憶測 about a 375p a 株 US 企て，努力，提案 for oil services group Abbot 強めるd and the の近くに was 26?p up at 351p.

Waste 管理／経営 group Biffa rose 11p to 336p after 拒絶するing a second 330p-a-株 申し込む／申し出 from 私的な 公正，普通株主権 会社／堅いs Montagu and HgCapital. Lehman Bros' take-out price is £4.

Vislink, a 供給者 of microwave 無線で通信する and 衛星 伝達／伝染 製品s, 辛勝する／優位d up to 49p after winning two 重要な orders for its US broadcast 商売／仕事, MRC, for £12.5m.

Vyke Communications, the 動きやすい VoIP service provider, jumped 10p to 120?p. 買い手s switched on the 開始する，打ち上げる of its service with the Cloud 網状組織 which 許すs Vyke 顧客s positioned in Cloud hotspots to make cheap international calls with cost 貯金 up to 95%.

? 目的（とする）-名簿（に載せる）／表（にあげる）d 麻薬 deve lopment company Curidium Medica, which specialises in ' personalised 薬／医学', 改善するd ?p to 3?p after entering into a 戦略の 共同 with Takeda 研究 投資 (TRI), the 法人組織の／企業の arm of the largest 麻薬s company in Japan. TRI will be buying 10.5m 株 and 令状s in CM and the company will use the cash proceeds to 始める その上の 研究 into major 不景気 disorders.